| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.9 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.9 |